AVM Biotechnology
- Home
- Companies
- AVM Biotechnology
- Services
1 services found
AVM Biotechnology services
Cancer Treatment Services
AVM0703 Induces & Mobilizes Gamma Delta+ NKT-Cells. AVM0703 triggers the production and release of gamma delta+ Natural Killer T-cells (AVM-NKT). These supercharged immune cells have unique properties and appear rapidly in the blood following a single dose of AVM0703. They home to abnormal cells including cancer, infected cells and autoreactive lymphocytes. It is clear that these cells could play a significant role in addressing several serious conditions.
